内镜下评分系统在炎症性肠病达标治疗中的重要性综述
本综述讨论炎症性肠病中最常用的内镜评分系统及应答与缓解的定义,并阐述如何将其整合到达标治疗策略中以优化患者结局。内镜下缓解(黏膜愈合)已成为关键治疗目标,评分系统可增加客观性与标准化。
要点
- 内镜评估是黏膜疾病活动度、预后及治疗应答判断的金标准。
- 达标治疗指早期治疗高风险患者以预防或限制肠道损伤。
- 内镜评分系统增加客观性与标准化,辅助临床决策。
核心结论
- 内镜评分系统可增加客观性与标准化,辅助黏膜表现的报告与临床决策。
- 内镜下缓解(黏膜愈合)已成为炎症性肠病治疗的关键目标。
- 将内镜评分系统整合到达标治疗策略中有助于优化患者结局。
研究设计与样本
- 综述,讨论克罗恩病与溃疡性结肠炎中最常用的内镜评分系统及应答与缓解的定义。
主要发现
- 症状与疾病活动客观指标之间可能存在分离,不受控炎症可导致进行性肠道损伤与不可逆肠损害。
- 目前尚无经验证的内镜下黏膜缓解定义。
- 现有大量评分系统用于定义克罗恩病与溃疡性结肠炎的活动度、应答与缓解。
关键数值与推荐
- 达标治疗定义为对疾病进展高风险患者早期治疗以预防或限制肠道损伤或残疾。
- 内镜评估是诊断、评估黏膜疾病活动度、预后、监测异型增生及评估治疗应答的金标准。
临床怎么用
- 使用内镜评分系统标准化黏膜表现的报告,辅助临床决策。
- 将内镜评分与应答、缓解定义整合到达标治疗策略中以优化患者结局。
局限性
- 目前尚无经验证的内镜下黏膜缓解定义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endoscopic assessment is currently the criterion standard for the diagnosis and assessment of mucosal disease activity, prognosis and monitoring for dysplasia, and assessment of response to therapy. Wider appreciation of the potential disconnect between symptoms and objective measures of disease activity and evidence that uncontrolled inflammation may lead to progressive intestinal injury and irreversible bowel damage with adverse events has led to the concept of treating to target. Treating to target is defined as treating patients with high risk for disease progression early to prevent or limit intestinal injury or disability. Endoscopic remission (mucosal healing) has emerged as a key goal of therapy. Although there are no currently validated definitions of endoscopic mucosal remission, the use of endoscopic scoring systems add uniformity and objectivity and aid standardization with reporting of mucosal appearance, augmenting clinical decision making. A plethora of scoring systems exist to define activity, response, and remission in both Crohn's disease and ulcerative colitis. In this review, we discuss the most commonly used endoscopic scoring systems and proposed definitions of response and remission, and how they can be integrated into a treat-to-target approach to optimize patient outcomes.
引用
- Limdi JK, Picco M, Farraye FA, et al. A review of endoscopic scoring systems and their importance in a treat-to-target approach in inflammatory bowel disease (with videos). Gastrointest Endosc. 2019. PMID: 31786161. doi:10.1016/j.gie.2019.11.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。